For citations:

Alekseev B.Ya., Shevchuk I.M. Evaluation of the efficacy and safety of cabazitaxel in combination with prednisone in patients with metastatic castration-resistant prostate cancer who have previously received docetaxel chemotherapy in daily clinical practice. Results of a Russian multicenter prospective study. Cancer Urology. 2020;16(1):66-77. (In Russ.) https://doi.org/10.17650/1726-9776-2020-16-1-66-77